Next Generation Environmental Friendly Antibiotics
Professor, Department of Structural Biology,Weizmann Institute
Precision Medicine: Fuel the Momentum to Drive a Healthier China
President, Greater China, Thermo Fisher Scientific China
professor,Director,Institutes of Biomedical Sciences Fudan University, Fudan University Shanghai Medical College
Therapeutic antibody development for non-oncology targets
Senior Director of Biologics, Shanghai Hengrui R&D center
Immunization with Heterogous HIV Env Immunogens Raises Broadcross-Reactive Neutralization Antibodies
Deputy Director，Shanghai Public Health Clinical Center,Institutes of Biomedical Sciences Fudan University
Immunologic approaches to HIV cure
Professor，University of North Carolina-Chapel Hill
Safe and Effective MERS-CoV Vaccine Development
Director, Fudan University Shanghai Medical College
Study on Long Term Protective Mechanism of Hepatitis A Vaccine
Deputy Director,Institutes of Biomedical Sciences Fudan University,National Engineering Laboratory for Therapeutic Vaccines
Construction of Information and technology platforms for regional Life & healthcare industry development
Deputy Director, Industry Development Department at Deputy Director, Industry Development Department
Drug Development & Regulatory Strategy Under ICH
President, Fountain Medical Development Ltd.
Current Challenges of Innovative Drug Development in China and in US
Polymer Microneedles for Drug and Vaccine Delivery
professor，College of Materials Science and Engineering, Beijing University of Chemical Technology
Outlook of Precision Medicine Development and Livzon’s Strategies
Vice President,Livzon Pharmaceuticals Group
Delivering R&D Excellence in China
VP R&D,Amgen BioPharmaceutical R&D (Shanghai) Co., Ltd.
Biopharmaceutical Manufacturing Vision of the Future
Senior Vice President, BioVentures, AstraZeneca
Targeting human gammadelta-T cells to control influenza and EBV infections
Director,Li Ka Shing Faculty of Medicine, The University of Hong Kong
Key Points and Concerns of Allergy Test on Vaccines
Chief Technology Officer of the GLP Department ,TIPR Drug Assessment Co.Ltd
QbD: Allotypes of Therapeutic mAbs
Chief Technology Officer & Head of Quality, Genor BioPharma Co., Ltd.
Novel isoelectric focusing techniques and instruments for protein drug analyses and purification
Head of Bioseparation-Analytical Biochemistry Laboratory, Shanghai Jiao Tong University
The path from bench to bedside :successful development of quality cell products
Principal Scientist,Cell Therapy Development Services ，Lonza INC
Technology Advances and Trends on Minimally Invasive Medical Devices
Vice President, Shanghai MicroPort Medical (Group) Co., Ltd.
Application of Quality by Design in Quality Consistency Evaluation on Generic Drug Product
Senior director of PDS, LTD,WuXi AppTec (Shanghai) Co., Ltd.
Development of Spine MIS Technology
Chairman, Chief Scientist,SHANGHAI SANYOU MEDICAL CO., LTD
The Advances in Thermal Ablation for Interventional Oncology – Novel Microwave Ablation Technology
Productdevelopment manager,Medtronic China R&D Center
Data Accuracy and Reliability of Clinical Bioanalysis and How to Meet the Requirement of Regulatory Agency’s Inspection
Senior director of BAS, LTD, WuXi AppTec (Shanghai) Co., Ltd.
Dissolution and Quality Study for Generic Drug Consistency Evaluation
Senior Director of ASU, LTD, WuXi AppTec (Shanghai) Co., Ltd.
Global Contract Manufacturing Excellence in China Biopharmaceutical Market
Associate Director, Business Development & Key Account Management, China，Company: Boehringer Ingelheim Biopharmaceutical (China) Co., Ltd.
Development and Clinical Application of Orthopedic Surgical Robot
Channel Sale Director, TINVAVI Medical Technologies Co., Ltd.
A Novel and High Throughput System for Drug Discovery against HIV-1 Multi-protease Inhibitor Resistance
Richard Y. Zhao
Professor，University of Maryland School of Medicine